TrialNutrition journal2012

A randomized, double blind, placebo and active comparator controlled pilot study of UP446, a novel dual pathway inhibitor anti-inflammatory agent of botanical origin.

John S Sampalis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.